- Price
- $66.78
- Day
- -3.03%
- Mkt Cap
- $30.16B
- 52W Range
- $58.75 – $89.77
- Volume
- 3.06M
- Beta
- 0.82
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that StarGuide GX,i its new digital 4D CZT SPECT/CT technology, is 510(k) pending with the U.S. Food and Drug Administration (FDA). Building on the system's recent CE Mark, this milestone is a step towards expanding access to advanced molecular imaging technologies in the United States and marks a significant moment in molecular imaging's evolution – aiming to empower clinicians with a high-performance, general purpose scanner to help pers.
Hsbc Holdings PLC Has $64.22 Million Stake in GE HealthCare Technologies Inc. $GEHC
Hsbc Holdings PLC lifted its stake in GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 22.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,004,490 shares of the company's stock after acquiring an additional 186,800 shares during the period. Hsbc Holdings PLC owned 0.22%
GEHC Wins CE Mark for Photonova Spectra, Expands International Reach
GE HealthCare's Photonova Spectra gains CE Mark, expanding access to its Deep Silicon photon-counting CT technology across Europe and other CE markets.
GE HealthCare's Photonova™ Spectra gains CE Mark, expanding international access
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) recently achieved CE Mark for Photonova Spectra,i an advanced photon-counting computed tomography (PCCT) system with the company's proprietary Deep Silicon™ detector technology. The regulatory milestone expands access and enables clinical adoption of the technology in CE Mark–observing countries and underscores GE HealthCare's commitment to purposeful, customer-driven innovation in computed tomography (CT). “We are proud to deliver this new.
GEHC vs. HAE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Haemonetics (HAE). But which of these two stocks is more attractive to value investors?